10.1002/anie.202012122
Angewandte Chemie International Edition
COMMUNICATION
was observed during the protonation process (Scheme 6a).
Treatment of 1a with 1:1 mixture of deuterium-labelled (2c-D) and
non-isotope-labelled (2c) cyclopropanols delivered the addition
products with 22% D incorporation at the cyclopropane ring
(Scheme 6b), indicating that the proton transfer process might be
the rate-determining step (II®III or VII®3a, Scheme 6c).
Unexpectedly, we found that 10% deuterium was also
incorporated at ketone a-position. Control experiments revealed
that the addition product 5a cannot undergo enolization followed
by protonation to introduce deuterium, whereas enolization of the
Co homoenolate intermediate IV might occur under the reaction
conditions. Based on all the observations, the proposed catalytic
cycle is shown in Scheme 6c. The acetate that coordinated at Co
center underwent intramolecular deprotonation followed by b-C–
C bond cleavage to generate the Co homoenolate IV, which
added to the cyclopropene and protonated with HOAc to furnish
3a and regenerated the catalyst I.
Acknowledgements ((optional))
This work was financially supported by Strategic Priority
Research Program of the Chinese Academy of Sciences (Grant
No. XDB20000000), National Natural Science Foundation of
China (Grant No. 21702222, 21821002), Shanghai Rising-Star
Program (Grant No. 19QA1411000) and the Science and
Technology Commission of Shanghai Municipality (Grant No.
17JC1401200).
Keywords: cobalt • cyclopropanes • enantioselective catalysis•
hydroalkylation • small ring
[1]
For recent reviews, see: a) T. F. Schneider, J. Kaschel, D. B. Werz,
Angew. Chem. Int. Ed. 2014, 53, 5504–5523; Angew. Chem. 2014, 126,
5608–5628; b) D. T.-K. Chen, R. H. Pouwer, J.-A. Richard, Chem. Soc.
Rev. 2012, 41, 4631–4632; c) P. Tang, Y. Qin, Synthesis 2012, 44,
2969–2984; d) L. A. Wessjohann, W. Brandt, T. Thiemann, Chem. Rev.
2003, 103, 1625–1648.
O
7.5 mol % Co(OAc)2
7.5 mol % 4h
D D
(a)
Ph Me
H
Ph OH
Ph
+
MeCN (0.2 M), 10 oC, 12 h
[2]
a) S. R. Nagarajan, H.-F. Lu, A. F. Gasiecki, I. K. Khanna, M. D. Parikh,
B. N. Desai, T. E. Rogers, M. Clare, B. B. Chen, M. A. Russell, J. L.
Keene, T. Duffin, V. W. Engleman, M. B. Finn, S. K. Freeman, J. A.
Klover, G. A. Nickols, M. A. Nickols, K. E. Shannon, C. A. Steininger, W.
F. Westlin, M. M. Westlin, M. L. Williams, Bioorg. Med. Chem. 2007, 15,
3390–3412; b) N. N. Vachharajani, K. Yeleswaram, D. W. Boulton, J.
Pharm. Sci. 2003, 92, 760–772; c) T. Mizukami, A. Asai, Y. Yamashita,
R. Katahira, A. Hasegawa, K. Ochiai, S. Akinaga, U.S. Patent 5 663 298,
1997; Chem. Abstr. 1997, 126, 79; d) A. Asai, A. Hasegawa, K. Ochiai,
Y. Yamashita, T. Mizukami, J. Antibiotics 2000, 53, 81–83.
D
D
Ph
Me
1a-D
2a
3x
(1.5 equiv)
88% yield
>95:5 dr, 95:5 er
O
(b)
MeO
MeO
22% D
D/H
OH
OD
7.5 mol % Co(OAc)2
7.5 mol % 4h
2c
(0.5 equiv)
2c-D
(0.5 equiv)
H/D
OMe
Ph
Me
MeCN (0.2 M), 23 oC, 40 min
10% D
Ph Me
5a
30% conv., 28% yield
1a
O
O
7.5 mol % Co(OAc)2, 7.5 mol % 4h
MeCN (0.2 M), 23 oC, 12 h
20 mol % CD3CO2D, 2.5 equiv 2c-D
[3]
For selected reviews, see: a) G. Bartoli, G. Bencivenni, R. Dalpozzo,
Synthesis 2014, 46, 979–1029; b) H. Pellissier, Tetrahedron 2008, 64,
7041–7095; c) M. Rubin, M. Rubina, V. Gevorgyan, Chem. Rev. 2007,
107, 3117–3179; d) H. Lebel, J.-F. Marcoux, C. Molinaro, A. B. Charette,
Chem. Rev. 2003, 103, 977–1050; e) H. M. L. Davies, R. E. J. Beckwith,
Chem. Rev. 2003, 103, 2861–2904; f) A. B. Charette, A. Beauchemin,
Org. React. 2001, 58, 1–415.
OMe
Ph
Me
OMe
Ph
MeO
Me
5a
5a
>95% recovery, <5% D incorporation
O
5.0 mol % Co(OAc)2, 5.0 mol % 4h
OD
8% D
H/D
MeCN (0.3 M), 23 oC, 12 h
H/D
MeO
44% D
2c-D
12
11% yield
(c)
Proposed Catalytic Cycle
3a
P
P
Co
HOAc
[3]
[4]
a) M. P. Doyle, R. Duffy, M. Ratnikov, L. Zhou, Chem. Rev. 2010, 110,
704–724; b) M. P. Doyle, D. C. Forbes, Chem. Rev. 1998, 98, 911–936;
c) H. M. L. Davies, E. G. Antoulinakis, Org. React. 2001, 57, 1–326.
a) H. Shitama, T. Katsuki, Angew. Chem. Int. Ed. 2008, 47, 2450–2453;
Angew. Chem. 2008, 120, 2484–2487; b) A. B. Charette, C. Molinaro, C.
Brochu, J. Am. Chem. Soc. 2001, 123, 12168–12175; c) A. B. Charette,
H. Juteau, H. Lebel, C. Molinaro, J. Am. Chem. Soc. 1998, 120, 11943–
11952; d) S. E. Denmark, S. P. O’Connor, J. Org. Chem. 1997, 62, 584–
594; e) M. Montesinos-Magraner, M. Costantini, R. Ramírez-Contreras,
M. E. Muratore, M. J. Johansson, A. Mendoza, Angew. Chem. Int. Ed.
2019, 58, 5930–5935; Angew. Chem. 2019, 131, 5991–5996. f) M.-C.
Lacasse, C. Poulard, A. B. Charette, J. Am. Chem. Soc. 2005, 127,
12440–12441.
2a
AcO
OAc
I
P
P
P
P
Ph
Co
Co
O
O
OAc
Ph
Me
Ph
H
Me
O
P
P
VII
Co
OH
Ph
O
II
AcO
V
HOAc
Ph
P
P
Co
O
P
P
Co
Ph
O
Me
AcO
Ph
III
VI
P
P
Co
O
AcO
Ph
[5]
a) C. D. Papageorgiou, M. A. C. de Dios, S. V. Ley, M. J. Gaunt, Angew.
Chem. Int. Ed. 2004, 43, 4641–4644; Angew. Chem. 2004, 116, 4741–
4744; b) C. C. C. Johansson, N. Bremeyer, S. V. Ley, D. R. Owen, S. C.
Smith, M. J. Gaunt, Angew. Chem. Int. Ed. 2006, 45, 6024–6028; Angew.
Chem. 2006, 118, 6170–6175; c) H. Kakei, T. Sone, Y. Sohtome, S.
Matsunaga, M. Shibasaki, J. Am. Chem. Soc. 2007, 129, 13410–13411;
d) V. K. Aggarwal, E. Alonso, G. Fang, M. Ferrara, G. Hynd, M. Porcelloni,
Angew. Chem. Int. Ed. 2001, 40, 1433–1436; Angew. Chem. 2001, 113,
1482–1485; e) R. K. Kunz, D. W. C. MacMillan, J. Am. Chem. Soc. 2005,
127, 3240–3241. For a review, see: f) C. M. R. Volla, I. Atodiresei, M.
Rueping, Chem. Rev. 2014, 114, 2390–2431.
IV
Scheme 6. Preliminary mechanistic studies.
In conclusion, we have developed the first example of a Co-
catalyzed diastereo- and enantioselective hydroalkylation of
cyclopropenes via Co homoenolate intermediates generated from
ring-opening of a wide range of easily accessible cyclopropanols.
A high diversity of enantioenriched cyclopropanes can be
prepared through this highly efficient, stereoselective, and atom-
economical approach, promoted by an earth-abundant metal salt
and a commercially available chiral ligand. Further mechanistic
[6]
[7]
For a recent review, see: L. Dian, I. Marek, Chem. Rev. 2018, 118, 8415–
8434.
M. Rubina, M. Rubin, V. Gevorgyan, J. Am. Chem. Soc. 2004, 126,
3688–3689.
studies
and
stereoselective
hydrofunctionalization
of
cyclopropenes are underway.
4
This article is protected by copyright. All rights reserved.